Stay updated with breaking news from Value Based Care. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
:max_bytes(150000):strip_icc()/GettyImages-1483043017-306594f68aa2432eb8658506b3826d38.jpg)
Two new drugs from Eli Lilly—Leqembi and donanemab—are showing promising results of slowing Alzheimer's when the disease is in the early stages. Leqembi was approved by the FDA in January; donanemab is currently being considered for FDA approval.
The American Association of Orthopaedic Surgeons shared comments to the Center for Medicare and Medicaid Innovation regarding a request for information on developing episode-based payment models.
/PRNewswire/ -- EmblemHealth, one of the nation's largest nonprofit health insurers, today announced results from its national study exploring the level of...
Health systems are adapting to rising expenses and slim margins by accelerating value-based care strategies and taking a more nuanced approach to care. Hospital
SelectQuote, Inc. , a leading distributor of Medicare insurance policies and owner of an emerging Healthcare Services platform, announced today that it will release its fiscal fourth quarter and full...